U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07786441) titled 'KABAWIL: Reducing Intersectional Stigmas' on Aug. 17.
Brief Summary: The goal of this study is to develop and test KABAWIL, a culturally tailored intervention designed to reduce HIV-related and intersectional stigmas experienced by Indigenous communities in Guatemala and improve engagement across the HIV Continuum of Care. The study will also assess the feasibility, acceptability, and implementation of the intervention. The main questions it aims to answer are:
Can a culturally adapted version of the FRESH intervention reduce HIV-related and intersectional stigmas among Indigenous men and Indigenous healers? Does participation in K...